Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Nuvation Bio Inc (NUVB)

227 + Investors. Track Smart Money conviction in NUVB. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +6
Streak
9Q ▲
Buyers last Q
59%

Smart Money Signals — NUVB

Based on 228 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 9 quarters in a row

last 6Q
For 9 consecutive quarters, more hedge funds added NUVB than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
228 hedge funds hold NUVB right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +43% more funds vs a year ago

fund count last 6Q
+69 new funds entered over the past year (+43% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 59% buying

138 buying97 selling
Last quarter: 138 funds bought or added vs 97 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-12 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 44 → 37 → 57 → 45. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

43% of holders stayed for 2+ years

■ 43% conviction (2yr+) ■ 28% medium ■ 29% new
97 out of 228 hedge funds have held NUVB for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +3%, value -52%

Value
-52%
Shares
+2%
Last quarter: funds added +3% more shares while total portfolio value only changed -52%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

23 → 44 → 37 → 57 → 45 new funds/Q
New funds entering each quarter: 44 → 37 → 57 → 45. A growing number of institutions are discovering NUVB each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 53% of holders stayed 2+ years

■ 53% veterans ■ 11% 1-2yr ■ 36% new
Of 233 current holders: 123 (53%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 45% AUM from top-100 funds

45% from top-100 AUM funds
48 of 228 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in NUVB. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.2
out of 10
Moderate Exit Risk
Exit risk score 4.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — NUVB

In 2026 Q1, 138 hedge funds were net buyers of NUVB (45 opened a new position, 93 added to an existing one), while 97 reduced or exited (58 trimmed, 39 sold completely) — a 59% buyer ratio, indicating a slight buying edge. This marks 9 consecutive quarters of net institutional buying — a persistent conviction signal. 45% of total institutional value in NUVB is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +6 funds (more new holders than closures). Total institutional holders: 228.

Hedge Fund Ownership: NUVB

How many hedge funds hold NUVB — quarterly history vs. share price
Quarterly hedge fund ownership of NUVB vs. share price

Market Analysis: NUVB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NUVB

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Nuvation Bio Inc (NUVB) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much NUVB has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 74d ago
NUVB
+14.7%
XLV
+4.9%

NUVB outperformed XLV by +9.8% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 29d ago
NUVB
+13.9%
XLV
+6.0%

Since the filing became public, NUVB outperformed XLV by +7.9% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

22 top-rated funds 4 high-conviction
Consensus
5.9
/ 10
breadth
×
Elite
3.2
/ 10
conviction
Hedge Fund Positioning: NUVB
227 + Investors

Track Smart Money conviction in NUVB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 227 222 2.25%
13F Shares 222M 216M 2.91%
Total Value $916M $1.91B -51.95%
New Positions 44 57 -13
Increased Positions 91 69 +22
Closed Positions 39 35 +4
Reduced Positions 57 69 -12
Total Calls 4 4 -
Total Puts 3 3 -
PUT/CALL Ratio 0.75 0.75 Neutral

Statistics: NUVB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

227 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NUVB. Verified SEC 13F-HR filings.

QUARTER:
Top 25 NUVB holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Omega Fund Management, LLC 21.25% 8,081,089 $34.7M
2 Decheng Capital LLC 16.84% 25,954,439 $111.3M
3 Knoll Capital Management, LLC 3.57% 1,498,591 $6.4M
4 Jones Hill Capital LP 2.19% 2,383,031 $10.2M
5 Laurion Capital Management LP 1.46% 7,822,638 $33.6M
6 Act Capital Management, LLC 0.98% 290,000 $1.2M
7 Redmile Group, LLC 0.90% 3,153,256 $13.5M
8 Propel Bio Management, LLC 0.89% 329,296 $1.4M
9 Tang Capital Management LLC 0.69% 3,149,557 $13.5M
10 Palo Alto Investors LP 0.33% 508,846 $2.2M
11 Intellectus Partners, LLC 0.25% 290,417 $1.2M
12 Armistice Capital, LLC 0.13% 1,736,000 $7.4M
13 Virtus Investment Advisers, LLC 0.12% 100,151 $430K
14 Abrams Capital Management, L.P. 0.12% 1,270,504 $5.5M
15 Tema Etfs LLC 0.11% 392,754 $1.7M
16 Palumbo Wealth Management LLC 0.11% 100,963 $433K
17 Odyssean, LLC 0.10% 63,097 $271K
18 Hussman Strategic Advisors, INC. 0.10% 105,000 $450K
19 Diametric Capital, LP 0.08% 67,627 $290K
20 Wexford Capital LP 0.08% 120,889 $519K
21 Hennion & Walsh Asset Management, Inc. 0.07% 450,594 $1.9M
22 Shay Capital LLC 0.06% 175,056 $751K
23 Scientech Research LLC 0.05% 15,017 $64K
24 Ami Asset Management Corp 0.05% 192,427 $826K
25 Axq Capital, LP 0.05% 84,710 $363K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Nuvation Bio Inc (NUVB)

What does the Smart Money Trend signal show for NUVB?

Buying streak — 9 quarters in a row: For 9 consecutive quarters, more hedge funds added NUVB than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for NUVB?

Slight buying edge — 59% buying: Last quarter: 138 funds bought or added vs 97 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for NUVB holders?

Elite ownership — 45% AUM from top-100 funds: 48 of 228 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in NUVB. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held NUVB?

43% of holders stayed for 2+ years: 97 out of 228 hedge funds have held NUVB for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Nuvation Bio Inc (NUVB) following the 2026 Q1 hedge fund 13F filings?

As of today, NUVB has moved +13.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of +7.9%. Since the quarter end (March 31, 2026), NUVB has gained +14.7% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →